TDO2 and oropharynx squamous cell carcinoma: Subsequent exploration of expression variations in these genes across diverse HPV statuses uncovered a significant divergence in the expression of TDO2 and ZDHHC9 between patients with HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma, with lower expression observed in HPV-positive individuals (Figure 8A).